Inventor

Robert Murray McKinnell

Inventor
Millbrae, CA, US

Overview

67→
Patents
2005–2021
Patent span
Human necessities
Primary field (CPC A)

Patents· 67 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations33%
C07DHeterocyclic compounds33%
A61KPreparations for medical, dental or toiletry purposes21%
C07CAcyclic or carbocyclic compounds5%
G01NInvestigating or analysing materials by determining their chemical or physical properties3%
C07BGeneral methods of organic chemistry3%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium1%
PatentTitleYear
10,988,470Pyrimidine compound as JAK kinase inhibitor202110,968,205Pyrazolo and triazolo bicyclic compounds as JAK kinase inhibitors202110,851,102Imidazole and triazole containing bicyclic compounds as JAK inhibitors202010,696,656Benzimidazole-carboxamide compounds as 5-HT202010,562,894Pyrimidine compound as JAK kinase inhibitor202010,538,513Pyrazolo and triazolo bicyclic compounds as JAK kinase inhibitors202010,392,368Pyrazolo and triazolo bicyclic compounds as JAK kinase inhibitors201910,308,646Pyrimidine compound as JAK kinase inhibitor201910,233,172Benzimidazole-carboxamide compounds as 5-HT20199,975,877Benzimidazole-carboxamide compounds as 5-HT20189,669,027'Hepatitis C virus inhibitors'20179,428,489'Benzimidazole-carboxamide compounds as 5-HT4 receptor agonists'20169,365,549'Hepatitis C virus inhibitors'20169,273,008'Dual-acting imidazole antihypertensive agents'20169,260,414'Inhibitors of hepatitic C virus'20169,216,970'Dual-acting thiophene, pyrrole, thiazole and furan antihypertensive agents'20159,212,168'Hepatitis C virus inhibitors'20159,206,159'Piperazine-piperidine compounds as hepatitis C virus inhibitors'20159,198,899'Dual-acting benzoimidazole antihypertensive agents'20159,181,206'Dual-acting oxazole antihypertensive agents'20159,150,514'Dual-acting antihypertensive agents'20159,066,944'Hepatitis C virus inhibitors'20159,012,485'Dual-acting imidazole antihypertensive agents'20158,946,233'Dual-acting thiophene, pyrrole, thiazole and furan antihypertensive agents'20158,921,372'Inhibitors of hepatitis C virus'20148,895,755'Intermediates for preparing dual-acting benzyl triazole antihypertensive agents having angiotensin II type I receptor antagonist activity and neprilysin-inhibition activity'20148,865,755'Dual-acting antihypertensive agents'20148,822,522'Dual-acting pyrazole antihypertensive agents'20148,735,625'Dual-acting antihypertensive agents'20148,664,227'Dual-acting thiophene, pyrrole, thiazole and furan antihypertensive agents'20148,664,254'Dual-acting imidazole antihypertensive agents'20148,637,676'Dual-acting benzoimidazole antihypertensive agents'20148,598,170'Dual-acting oxazole antihypertensive agents'20138,569,351'Dual-acting benzyl triazole antihypertensive agents having angiotensin II type receptor antagonist activity and neprilysin-inhibition activity'20138,513,432'Dual-acting benzoimidazole antihypertensive agents'20138,501,798'Dual-acting antihypertensive agents'20138,481,549'Dual-acting thiophene, pyrrole, thiazole and furan antihypertensive agents'20138,394,846'Dual-acting antihypertensive agents'20138,377,964'Benzimidazole-carboxamide compounds as 5-HT4 receptor agonists'20138,372,984'Dual-acting oxazole antihypertensive agents'20138,349,875'Dual-acting antihypertensive agents'20138,350,027'Dual-acting pyrazole antihypertensive agents'20138,344,013'Dual-acting imidazole antihypertensive agents'20138,338,418'Dual-acting antihypertensive agents'20128,236,846'Dual-acting antihypertensive agents'20128,236,839'Dual-acting antihypertensive agents'20128,227,497'Dual-acting antihypertensive agents'20128,212,052'Dual-acting benzoimidazole antihypertensive agents'20128,158,659'Dual-acting imidazole antihypertensive agents'20128,143,279'Benzimidazole-carboxamide compounds as 5-HT4 receptor agonists'20128,143,298'Dual-acting antihypertensive agents'20128,119,634'Dual-acting pyrazole antihypertensive agents'20128,106,082'Dual-acting antihypertensive agents'20128,080,572'Dual-acting antihypertensive agents'20118,013,005'Dual-acting antihypertensive agents'20117,994,165'Aryl aniline derivatives as β2 adrenergic receptor agonists'20117,989,484'Dual-acting antihypertensive agents'20117,956,054'Dual-acting pyrazole antihypertensive agents'20117,879,896'Dual-acting imidazole antihypertensive agents'20117,863,309'Dual-acting antihypertensive agents'20117,834,041'Dual-acting antihypertensive agents'20107,777,077'Dual-acting antihypertensive agents'20107,759,363'Benzimidazole-carboxamide compounds as 5-HT4, receptor agonists'20107,662,815'Diaryl ether β2 adrenergic receptor agonists'20107,622,467'Aryl aniline derivatives as β2 adrenergic receptor agonists'20097,317,023'Diaryl ether β2 adrenergic receptor agonists'20086,867,299'Oxamide IMPDH inhibitors'2005

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2005Based in London, GB· patent location history
2008–2014Patents assigned to THERAVANCE INC (39)· patent assignee history
2008–2014Based in Half Moon Bay, CA, US· patent location history
2011–2016Patents assigned to MCKINNELL ROBERT MURRAY (40)· patent assignee history
2011–2016Patents assigned to FATHEREE PAUL R (32)· patent assignee history
2011–2016Patents assigned to CHOI SEOK-KI (24)· patent assignee history
2011–2016Patents assigned to GENDRON ROLAND (21)· patent assignee history
2011–2021Based in Millbrae, CA, US· patent location history
2020Based in South San Francisco, CA, US· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
MCKINNELL ROBERT MURRAYself402011–2016
THERAVANCE INC392008–2014
FATHEREE PAUL R322011–2016
CHOI SEOK-KI242011–2016
GENDRON ROLAND212011–2016
Locations
LocationPatentsSpan
Millbrae, California, US512011–2021
Half Moon Bay, California, US132008–2014
South San Francisco, California, US22020
London, GB12005